APM
Avidity Partners Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,400
| Closed | -$16.1M | – | 75 |
|
|
2025
Q1 | $16.1M | Buy |
25,400
+17,000
| +202% | +$10.8M | 3.07% | 7 |
|
|
2024
Q4 | $5.98M | Buy |
+8,400
| New | +$5.98M | 0.59% | 48 |
|
|
2024
Q3 | – | Sell |
-48,000
| Closed | -$50.4M | – | 99 |
|
|
2024
Q2 | $50.4M | Sell |
48,000
-20,000
| -29% | -$21M | 2.14% | 13 |
|
|
2024
Q1 | $65.4M | Hold |
68,000
| – | – | 2.11% | 13 |
|
|
2023
Q4 | $59.7M | Buy |
68,000
+10,000
| +17% | +$8.78M | 2.18% | 13 |
|
|
2023
Q3 | $47.7M | Buy |
58,000
+33,200
| +134% | +$27.3M | 1.92% | 16 |
|
|
2023
Q2 | $17.8M | Sell |
24,800
-94,300
| -79% | -$67.8M | 0.62% | 56 |
|
|
2023
Q1 | $97.9M | Buy |
+119,100
| New | +$97.9M | 3.25% | 6 |
|
|
2021
Q4 | – | Sell |
-152,300
| Closed | -$92.2M | – | 109 |
|
|
2021
Q3 | $92.2M | Buy |
+152,300
| New | +$92.2M | 2.04% | 9 |
|
|
2020
Q3 | – | Sell |
-132,100
| Closed | -$82.4M | – | 82 |
|
|
2020
Q2 | $82.4M | Buy |
132,100
+82,100
| +164% | +$51.2M | 5.28% | 2 |
|
|
2020
Q1 | $24.4M | Buy |
+50,000
| New | +$24.4M | 3.37% | 6 |
|